Zobrazeno 1 - 10
of 53
pro vyhledávání: '"2DR"'
Autor:
Elaine Monteiro Matsuda, Ivana Barros Campos, Isabela Penteriche de Oliveira, Daniela Rodrigues Colpas, Giselle Ibete Silva López-Lopes, Victor Oliveira Chiavegato, Luís Fernando de Macedo Brígido
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss 3, Pp 102757- (2023)
Background: Two-Drug Regimens (2DR) have proven effective in clinical trials but real-world data, especially in resource-limited settings, is limited. Objectives: To evaluate viral suppression of lamivudine-based 2DR, with dolutegravir or ritonavir-b
Externí odkaz:
https://doaj.org/article/60b70075092646f68d1b81a8558c7a0d
Autor:
Carlos Dueñas-Gutiérrez, Luis Buzón, Roberto Pedrero-Tomé, José A. Iribarren, Ignacio De los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, Julia Gómez, Jesús Troya
Publikováno v:
Viruses, Vol 15, Iss 4, p 936 (2023)
Background: The high effectiveness and safety of the two-drug (2DRs) strategy using dolutegravir (DTG) plus lamivudine (3TC) have led to international guidelines recommending their use for treatment-naive HIV patients. In virologically suppressed pat
Externí odkaz:
https://doaj.org/article/999b575dbb0e492eb9a121410025beff
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 185-208 (2020)
Abstract Introduction As HIV has become a manageable chronic condition, a renewed and increased interest in challenging traditional three-drug HIV therapies and moving toward two-drug regimens (2DR) for initial or maintenance treatment in people livi
Externí odkaz:
https://doaj.org/article/3dc89ae3501847e8a0508d886c410d5f
Autor:
Vincenzo Malagnino, Romina Salpini, Elisabetta Teti, Mirko Compagno, Ludovica Ferrari, Tiziana Mulas, Valentina Svicher, Marta Zordan, Monica Basso, Giuliana Battagin, Sandro Panese, Maria Cristina Rossi, Renzo Scaggiante, Daniela Zago, Marco Iannetta, Saverio Giuseppe Parisi, Massimo Andreoni, Loredana Sarmati
Publikováno v:
Viruses, Vol 15, Iss 1, p 193 (2023)
The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of HIV viremia in patients living with HIV (PLWH) who switch to two-drug antiretroviral therapy (2DR) con
Externí odkaz:
https://doaj.org/article/d363faf005fa4ca5abcb95924980bbbd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carmen Hidalgo-Tenorio, David Vinuesa, Coral García-Vallecillos, Leopoldo Muñoz-Medina, Sergio Sequera, Rosario Javier, Miguel Ángel López-Ruz, Svetlana Sadyrbaeva-Dolgova, Juan Pasquau
Publikováno v:
Viruses, Vol 14, Iss 12, p 2626 (2022)
Two-drug regimens (2DRs) are emerging in clinical practice guidelines as treatment option for both naive and treatment-experienced people living with HIV (PLHIV). Objectives: To determine the real-life effectiveness of 2DR with 25 mg RPV plus 50 mg D
Externí odkaz:
https://doaj.org/article/ca0738d9b9ec405e9150637edeacdf06
Publikováno v:
Microorganisms, Vol 10, Iss 2, p 433 (2022)
During the last 30 years, antiretroviral treatment (ART) for human immunodeficiency virus (HIV) infection has been continuously evolving. Since 1996, three-drug regimens (3DR) have been standard-of-care for HIV treatment and are based on a protease i
Externí odkaz:
https://doaj.org/article/49dcef01c97545b795957a32881641dd
Autor:
Vincenzo Malagnino, Elisabetta Teti, Mirko Compagno, Luigi Coppola, Romina Salpini, Valentina Svicher, Monica Basso, Giuliana Battagin, Sandro Panese, Maria Cristina Rossi, Renzo Scaggiante, Daniela Zago, Marco Iannetta, Saverio Giuseppe Parisi, Massimo Andreoni, Loredana Sarmati
Publikováno v:
Microorganisms, Vol 9, Iss 2, p 396 (2021)
The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of Human Immunodeficiency Virus (HIV) viremia in patients living with HIV (PLWH) who switch a to two-drug
Externí odkaz:
https://doaj.org/article/39926933ac9543d284b0b3fb1a459efc
Autor:
Troya, Jesús, Pedrero-Tomé, Roberto, Buzón, Luis, Dueñas, Carlos, Group, on behalf of the SPADE Study Group on behalf of the SPADE Study
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 1176
Volume 12
Issue 3
Pages: 1176
Background: Immune recovery in people living with HIV (PLWHIV) is a residual aspect of antiretroviral treatment (ART) in most patients, but in a non-negligible proportion of them, the CD4+ lymphocytes count, or CD4/CD8 ratio remains suboptimal. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f8db44ab262753234fb758bf0c64d6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.